Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnitine for Prevention of CIPN in Metastatic Breast Cancer
NCT00754767Phase 4Terminated
- Sponsor
- HealthPartners Institute
- Start
- Jan 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of l-carnitine tartrate in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by HealthPartners Institute. Started Jan 2007; status: terminated.
02
Drugs
l-carnitine tartrate
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT00754767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00754767.